Embecta Corp. (EMBC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.
The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Country | United States |
IPO Date | Mar 22, 2022 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,200 |
CEO | Devdatt Kurdikar |
Contact Details
Address: 300 Kimball Drive Parsippany, New Jersey United States | |
Website | https://www.embecta.com |
Stock Details
Ticker Symbol | EMBC |
Exchange | NASDAQ |
Fiscal Year | October - September |
Reporting Currency | USD |
CIK Code | 0001872789 |
CUSIP Number | 29082K105 |
ISIN Number | US29082K1051 |
Employer ID | 87-1583942 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Devdatt Kurdikar | President, Chief Executive Officer & Director |
Colleen Riley | Senior Vice President & Chief Technology Officer |
Jacob P. Elguicze | Senior Vice President & Chief Financial Officer |
Ginny Blocki | Senior Vice President of Global Marketing & Product Management |
Jean M. Casner | Senior Vice President & Chief Human Resources Officer |
Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary |
Pravesh Khandelwal | Vice President & Head of Investor Relations |
Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain |
Slobodan Radumilo | Senior Vice President & President of International |
Tom Blount | Senior Vice President & President of North America |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 19, 2024 | ARS | Filing |
Dec 19, 2024 | DEFA14A | Filing |
Dec 19, 2024 | DEF 14A | Filing |
Dec 11, 2024 | 10-K | Annual Report |
Dec 04, 2024 | 4 | Filing |
Dec 04, 2024 | 3 | Filing |
Dec 02, 2024 | 8-K | Current Report |
Nov 29, 2024 | NT 10-K | Filing |
Nov 29, 2024 | 4 | Filing |
Nov 29, 2024 | 4 | Filing |